Craft

Targeted Medical Pharma

Stock Price

$0

2024-10-29

Market Capitalization

$323 K

2024-10-29

Revenue

$5.3 M

FY, 2015

Targeted Medical Pharma Summary

Company Summary

Overview
Targeted Medical Pharma, Inc. is a biotechnology company that develops amino acid based medical foods for the treatment of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders.The Company manufactures proprietary amino acid based medical foods, and the dietary supplements Theraleve and Clearwayz. Each product uses Targeted Cellular Technology, the Company's patented micro-nutrient delivery system that improves the absorption and cellular utilization of amino acids, nutrients and neurotransmitters. The products are manufactured in the United States and sold directly to physicians, pharmacies and patients in the United States, Japan and China.
Type
Public
Status
Active
Founded
1999
HQ
Los Angeles, CA, US | view all locations
Website
https://tmedpharma.com/index.php
Cybersecurity rating
Sectors

Key People

  • Marcus Charuvastra

    Marcus Charuvastra, Managing Director

  • William B. Horne

    William B. Horne, Chief Financial Officer

LocationsView all

1 location detected

  • Los Angeles, CA HQ

    United States

    2980 Beverly Glen Cir

Targeted Medical Pharma Financials

Summary Financials

Revenue (FY, 2015)
$5.3M
Gross profit (FY, 2015)
$3.2M
Net income (FY, 2015)
($3.1M)
Cash (FY, 2015)
$82.6K
EBIT (FY, 2015)
($2.0M)
Enterprise value
$5.0M

Footer menu